| Mepha Pharma AG - Budesonid-Mepha, Hartkapsel mit veränderter Wirkstofffreisetzung 3mg | | 68470 | | 01 | | Budesonid-Mepha, Hartkapsel mit veränderter Wirkstofffreisetzung 3mg | | | | A07EA06 | | Budesonide | | 08.07.2022 | | |
| | Composition | | budesonidum 3 mg, sacchari sphaerae corresp. saccharum 187.5 - 276 mg et maydis amylum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, ammonio methacrylatis copolymerum B, ammonio methacrylatis copolymerum A, triethylis citras, talcum, Kapselhülle: E 133, E 104, E 127, E 171, gelatina, natrii laurilsulfas corresp. natrium 0.005 mg, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, talcum, glyceroli monocaprylocapras, poly(alcohol vinylicus), pro capsula. | | Packungsbestandteile | | Active Agent | Dose |
|---|
| Budesonide | 3 mg |
| | Inactive agents | | additional_information |
|---|
| Acidi Methacrylici | | | | Ammonio Methacrylatis Copolymerum A | | | | Ammonio Methacrylatis Copolymerum B | | | | Copolymerum Macrogolo et Alcoholi Poly(Vinylico) Constatum | | Überzug | | E 104 | | color. | | E 127 | | color. | | E 133 | | Kapselhülle | | E 171 | | color. | | Gelatina | | | | Glyceroli Monocaprylocapras | | | | Maydis Amylum | | | | Methylis Methacrylatis Polymerisatum | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | | | Pro Capsula | | | | Sacchari Sphaerae | | | | Talcum | | | | Triethylis Citras | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 50 | PR | PR | B | | Yes | | 002 | 100 | PR | PR | B | | Yes | | 003 | 100 | PR | PR | B | | Yes |
|
|
